Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lensar Inc. (LNSR:NASDAQ), powered by AI.
Lensar Inc. is currently trading at $6.18. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lensar Inc. on Alpha Lenz.
Lensar Inc.'s P/E ratio is -2.2.
“Lensar Inc. trades at a P/E of -2.2 (undervalued) with strong ROE of 324.1%. 3Y revenue CAGR of 18.2% highlights clear growth momentum.”
Ask for details →Lensar Inc. is renowned for its advancement in femtosecond laser technology, specifically designed for cataract surgery. As a medical technology company, Lensar focuses predominantly on offering innovative solutions that enhance the precision and effectiveness of cataract surgery procedures. Its flagship product, the Lensar Laser System, is engineered to provide surgeons with superior imaging and laser guidance to perform precise cataract surgeries, thereby improving surgical outcomes and patient safety. Lensar operates at the intersection of healthcare and technology, influencing the ophthalmology sector significantly. By providing state-of-the-art laser systems, the company plays a critical role in advancing surgical standards and patient care in the rapidly growing field of eye health. Headquartered in Orlando, Florida, Lensar continues to contribute to medical technology through continuous research and development, reinforcing its position as a key player in promoting cutting-edge surgical solutions globally.
“Lensar Inc. trades at a P/E of -2.2 (undervalued) with strong ROE of 324.1%. 3Y revenue CAGR of 18.2% highlights clear growth momentum.”
Ask for details →Lensar Inc. (ticker: LNSR) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 140 employees. Market cap is $74M.
The current price is $6.18 with a P/E ratio of -2.16x and P/B of -2.84x.
ROE is 324.05% and operating margin is -42.06%. Annual revenue is $58M.